These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 27721253)
21. [Correlation of CpG methylation status of Runx3 with pathogenesis of gastric carcinoma]. Tang GH; Sun SW; He XS Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):314-9. PubMed ID: 22883670 [TBL] [Abstract][Full Text] [Related]
23. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis. Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219 [TBL] [Abstract][Full Text] [Related]
24. Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients. Zheng Y; Zhang Y; Huang X; Chen L Hepatogastroenterology; 2011; 58(112):2007-11. PubMed ID: 22234069 [TBL] [Abstract][Full Text] [Related]
25. RUNX3 Epigenetic Inactivation Is Associated With Estrogen Receptor Positive Breast Cancer. Liu H; Yan Z; Yin Q; Cao K; Wei Y; Rodriguez-Canales J; Ma D; Wu Y J Histochem Cytochem; 2018 Oct; 66(10):709-721. PubMed ID: 30133331 [TBL] [Abstract][Full Text] [Related]
26. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
27. Critical regions and spreading of runt-related transcription factor-3 C-phosphate-G (CpG) island methylation in human salivary gland adenoid cystic carcinoma. Ge MH; Chen C; Xu JJ; Ling ZQ Hum Pathol; 2011 Dec; 42(12):1862-72. PubMed ID: 21658745 [TBL] [Abstract][Full Text] [Related]
28. Relationship between RUNX3 methylation and hepatocellular carcinoma in Asian populations: a systematic review. Lu XX; Zhu LQ; Pang F; Sun W; Ou C; Li Y; Cao J; Hu YL Genet Mol Res; 2014 Jul; 13(3):5182-9. PubMed ID: 25061743 [TBL] [Abstract][Full Text] [Related]
29. Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer. Kurklu B; Whitehead RH; Ong EK; Minamoto T; Fox JG; Mann JR; Judd LM; Giraud AS; Menheniott TR Oncogene; 2015 May; 34(22):2856-66. PubMed ID: 25088199 [TBL] [Abstract][Full Text] [Related]
30. Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment. Llorca-Cardeñosa MJ; Fleitas T; Ibarrola-Villava M; Peña-Chilet M; Mongort C; Martinez-Ciarpaglini C; Navarro L; Gambardella V; Castillo J; Roselló S; Navarro S; Ribas G; Cervantes A Oncotarget; 2016 Sep; 7(39):63424-63436. PubMed ID: 27566570 [TBL] [Abstract][Full Text] [Related]
31. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Lee SH; Kim J; Kim WH; Lee YM Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007 [TBL] [Abstract][Full Text] [Related]
32. Spreading of methylation within RUNX3 CpG island in gastric cancer. Homma N; Tamura G; Honda T; Matsumoto Y; Nishizuka S; Kawata S; Motoyama T Cancer Sci; 2006 Jan; 97(1):51-6. PubMed ID: 16367921 [TBL] [Abstract][Full Text] [Related]
33. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells. Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375 [TBL] [Abstract][Full Text] [Related]
34. Association Between Tissue Inhibitor of Metalloproteinase-3 Gene Methylation and Gastric Cancer Risk: A Meta-Analysis. Cao J; Li Z; Yang L; Liu C; Luan X Genet Test Mol Biomarkers; 2016 Aug; 20(8):427-31. PubMed ID: 27314831 [TBL] [Abstract][Full Text] [Related]
35. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423 [TBL] [Abstract][Full Text] [Related]
36. An early biomarker and potential therapeutic target of RUNX 3 hypermethylation in breast cancer, a system review and meta-analysis. Lu DG; Ma YM; Zhu AJ; Han YW Oncotarget; 2017 Mar; 8(13):22166-22174. PubMed ID: 27825140 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and prognostic significance of the RUNX3 expression in gastric cancer: a systematic review and meta-analysis. Liu B; Han Y; Jiang L; Jiang D; Li W; Zhang T; Zu G; Zhang X Int J Surg; 2018 May; 53():122-128. PubMed ID: 29578091 [TBL] [Abstract][Full Text] [Related]
38. Runt-related Transcription Factor 3 Promoter Hypermethylation and Gastric Cancer Risk: A Meta-analysis. Lina M; Changan W; Qing Z Open Life Sci; 2018 Jan; 13():64-70. PubMed ID: 33817069 [TBL] [Abstract][Full Text] [Related]
39. [Reappraisal of the impacts of human Runt-related transcription factor gene 3 expression on differentiation and prognosis of gastric cancer]. Wu BW; Zhang J; Fei XF; Zhu ZG; Cao WX Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Mar; 10(2):165-8. PubMed ID: 17380460 [TBL] [Abstract][Full Text] [Related]
40. RUNX3 gene methylation in epithelial ovarian cancer tissues and ovarian cancer cell lines. Zhang S; Wei L; Zhang A; Zhang L; Yu H OMICS; 2009 Aug; 13(4):307-11. PubMed ID: 19645591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]